Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9
- 2 August 2012
- journal article
- Published by Informa UK Limited in Pharmaceutical Biology
- Vol. 50 (10), 1210-1218
- https://doi.org/10.3109/13880209.2012.664151
Abstract
Context: Nobiletin is one of the citrus bioflavonoids and can be found in citrus fruits such as lemons, oranges, tangerines, and grapefruits. The most studied properties of nobiletin are its anti-inflammatory and anticancer activities. Objective: The exact mechanisms of how nobiletin inhibits tumor metastasis and invasion are still not fully understood. In this study, we screened various natural compounds to down-modulate the CXC chemokine receptor-4 (CXCR4) and matrix metallopeptidase-9 (MMP-9). Materials and methods: The effect of nobiletin on the constitutive expressions of CXCR4 and MMP-9, MMP-9 enzymatic activity, associated nuclear factor κB (NF-κB) and mitogen-activated protein kinases (MAPKs) activation, and tumor cell invasion in human breast cancer cells was investigated. CXCR4 and MMP-9 expression were evaluated via reverse transcription polymerase chain reaction (RT-PCR) and western blotting. NF-κB activation was also evaluated by electrophoretic mobility shift assay (EMSA). In addition, the antimetastatic effects of nobiletin were determined by gelatin zymography and invasion assay. Results: Nobiletin down-regulated both the constitutive expressions of CXCR4 and MMP-9 in human breast cancer cells with IC50 values of 32 and 24 µM, respectively. Nobiletin also suppressed MMP-9 enzymatic activity and tumor cell invasion under noncytotoxic concentrations. Neither proteasome inhibition nor lysosomal stabilization had any effect on the nobiletin-induced decrease in CXCR4 expression. A detailed study of the underlying molecular mechanisms revealed that the regulation of the down-regulation of CXCR4 and MMP-9 were at the transcriptional level, as indicated by the down-regulation of mRNA expression and the suppression of the constitutive NF-κB and MAPKs activation. Discussion and conclusion: Our results indicate, for the first time, that nobiletin is a novel blocker of CXCR4 and MMP-9 expressions and thus has the potential to suppress metastasis of breast cancer.Keywords
This publication has 55 references indexed in Scilit:
- Arrestin-2 Interacts with the Ubiquitin-Protein Isopeptide Ligase Atrophin-interacting Protein 4 and Mediates Endosomal Sorting of the Chemokine Receptor CXCR4Journal of Biological Chemistry, 2007
- Nobiletin from citrus fruit peel inhibits the DNA-binding activity of NF-κB and ROS production in LPS-activated RAW 264.7 cellsJournal of Ethnopharmacology, 2007
- Tangeretin suppresses IL-1β-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cellsBiochemical Pharmacology, 2007
- γ-Tocotrienol Inhibits Nuclear Factor-κB Signaling Pathway through Inhibition of Receptor-interacting Protein and TAK1 Leading to Suppression of Antiapoptotic Gene Products and Potentiation of ApoptosisPublished by Elsevier BV ,2007
- Linkage between EGFR family receptors and nuclear factor kappaB (NF‐κB) signaling in breast cancerJournal of Cellular Physiology, 2006
- Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100.Mini-Reviews in Medicinal Chemistry, 2005
- Cancer and the chemokine networkNature Reviews Cancer, 2004
- Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cellsOncogene, 2004
- Axis of evil: molecular mechanisms of cancer metastasisOncogene, 2003
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002